Our Services and Solutions
We help pharma and biotech teams de-risk development with regulatory-aligned analytical and quality research. Our scientists deliver submission-ready data packages from method development and validation to impurity and nitrosamine/NDSRI studies, large molecule characterization (non-bioanalytical), E&L/CCIT, and reference standards across the full product lifecycle.
-
Nitrosamine & NDSRI Services
End-to-end support from risk assessment and method development to confirmatory testing and reporting.
-
In Vitro Bioequivalence
Regulatory-aligned in vitro models across dosage forms to support formulation development and BE strategy.
-
Large Molecule Characterization
Characterization of primary structure, higher-order structure (secondary/tertiary), impurity profiling, and aggregation/particle profiles to support CMC development, comparability, and regulatory submissions.
-
Analytical Method Development & Validation
Fit-for-purpose methods (HPLC/UPLC/GC and more) with validation documentation to support IND/NDA submissions.
-
Pharmaceutical & Medical Device Testing (E&L, Sterility, Biocompatibility)
Data to support container-closure safety and integrity, guided by QbD and PQRI best practices.
-
Nanoparticle Characterization
Physicochemical characterization to understand critical quality attributes and support comparability.
-
Reference Standards & Impurity Synthesis
Custom synthesis, isolation/purification, and structure elucidation to accelerate CMC timelines.
About Milestone Pharma
Milestone Pharma supports global pharma and biotech teams with pharmaceutical quality research across analytical development, impurity and nitrosamine/NDSRI studies, E&L/CCIT, and reference standards. Our focus is simple: deliver reliable, regulatory-aligned data you can use for decisions and filings.
-
10 + 10 +Years of Experience
-
290 + 290 +Scientists & Engineers
-
2,500 + 2,500 +Global Customers
-
10,000 + 10,000 +Projects Delivered
-
9,800 + m² 9,800 + m²Independent Laboratories
-
40% + 40% +MSc/PhD Ratio
Why Choose Us
A quality research CRO built for global filings. Here’s what you get when you partner with us:
-
Submission-ready, regulator-aligned deliverables
-
Audit-ready quality systems and data integrity
-
End-to-end quality research across the product lifecycle
-
Specialized expertise for complex modalities and high-risk impurities
-
A responsive partnership built around your milestones
-
01
Data packages and reports aligned with FDA/EMA/NMPA expectations
-
02
QA-reviewed documentation, traceability, and inspection support
-
03
From early development through post-approval changes
-
04
Advanced capabilities including nitrosamines/NDSRIs, E&L/CCIT, and reference standards
-
05
Right-sized scopes, fast iteration, and a single point of contact
Core Differentiators
Milestone Pharma is a pharmaceutical quality research CRO helping global teams build robust CMC and analytical strategies. We deliver high integrity, regulatory aligned data packages to support development, IND/NDA submissions, and post approval changes.
-
Regulatory-aligned approach designed for FDA, EMA, NMPA, and other global expectations
-
End-to-end analytical, impurity, and CMC quality solutions across the product lifecycle
-
Submission-ready reports, method packages, and documentation to support global filings and inspections
-
Integrated expertise across key platforms: nitrosamine/NDSRI, IVBE, E&L/CCIT, nanoparticles, and reference standards
-
Mar 09, 2026USP High Level Delegation Visits Milestone Pharma for In Depth Strategic Exchange
Explore More -
Dec 04, 2025Milestone Pharma Successfully Passes EU QP On Site Audit, Achieving Another Milestone in Regulatory Compliance
Explore More -
Dec 14, 2023Milestone Pharma Shanghai Facility Successfully Passes US FDA On Site Inspection with Zero Observations
Explore More -
Aug 08, 2023Milestone Pharma Nanjing Facility Successfully Passes US FDA On Site cGMP Inspection
Explore More
Discuss My Project
Speak with an expert about your upcoming project to see how we can help you.